- Home
- FHTX vs MIY Comparison
FHTX vs MIY Comparison
Compare FHTX & MIY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- MIY
- Stock Information
- Founded
- FHTX 2015
- MIY 1992
- Country
- FHTX United States
- MIY United States
- Employees
- FHTX N/A
- MIY N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- MIY Investment Bankers/Brokers/Service
- Sector
- FHTX Health Care
- MIY Finance
- Exchange
- FHTX Nasdaq
- MIY Nasdaq
- Market Cap
- FHTX 278.1M
- MIY 313.7M
- IPO Year
- FHTX 2020
- MIY N/A
- Fundamental
- Price
- FHTX $4.89
- MIY $11.33
- Analyst Decision
- FHTX Strong Buy
- MIY
- Analyst Count
- FHTX 8
- MIY 0
- Target Price
- FHTX $12.63
- MIY N/A
- AVG Volume (30 Days)
- FHTX 118.7K
- MIY 56.8K
- Earning Date
- FHTX 08-05-2025
- MIY 01-01-0001
- Dividend Yield
- FHTX N/A
- MIY 3.98%
- EPS Growth
- FHTX N/A
- MIY N/A
- EPS
- FHTX N/A
- MIY N/A
- Revenue
- FHTX $24,173,000.00
- MIY N/A
- Revenue This Year
- FHTX $33.60
- MIY N/A
- Revenue Next Year
- FHTX $5.87
- MIY N/A
- P/E Ratio
- FHTX N/A
- MIY N/A
- Revenue Growth
- FHTX N/A
- MIY N/A
- 52 Week Low
- FHTX $2.95
- MIY $9.45
- 52 Week High
- FHTX $10.25
- MIY $11.70
- Technical
- Relative Strength Index (RSI)
- FHTX 42.08
- MIY 69.68
- Support Level
- FHTX $4.72
- MIY $10.62
- Resistance Level
- FHTX $5.24
- MIY $11.35
- Average True Range (ATR)
- FHTX 0.41
- MIY 0.11
- MACD
- FHTX -0.16
- MIY 0.07
- Stochastic Oscillator
- FHTX 13.73
- MIY 89.04
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About MIY Blackrock MuniYield Michigan Quality Fund Inc.
Blackrock Muniyield Michigan Quality Fund Inc is a closed end fund. Its investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.